Lipodystrophy
Links shared publicly online about this topic
Lipodystrophy, Acquired Partial: eMedicine Endocrinology
emedicine.medscape.com — “Overview: Acquired partial lipodystrophy, also known as Barraquer-Simons syndrome or cephalothoracic lipodystrophy, is one of the rare forms of lipodystrophy. Mitchell initially reported this variety in 1885.1 Barraquer and Simons further characterized the syndrome at the ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:15 pm By:
A rare form of lipodystrophy, acquired partial lipodystrophy is also known as Barraquer-Simons syndrome. Learn more. http://bit.ly/bRKpTp
Lipodystrophy, Progressive: eMedicine Dermatology
emedicine.medscape.com — “Overview: Lipodystrophy syndromes represent a group of rare, heterogeneous disorders characterized by progressive loss of fat tissue, mainly from the subcutaneous compartment and occasionally from visceral fat.1 Subcutaneous loss of fat can occur as generalized or ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 19, 2010 at 6:16 pm By:
Progressive lipodystrophy is a rare condition in which fat accumulates in the upper body progressing downward. http://bit.ly/b5ESai
Lipodystrophy, Generalized: eMedicine Dermatology
emedicine.medscape.com — “Overview: Generalized lipodystrophy syndrome is the association of acanthosis nigricans (AN) with the generalized complete absence of subcutaneous fat and the presence of muscle hypertrophy, hyperlipemia, diabetes mellitus, and hepatosplenomegaly with cirrhosis. Two forms of this syndrome ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 21, 2010 at 10:20 pm By:
Generalized lipodystrophy (or Beradinelli-Seip syndrome) is a rare genetic skin condition. Learn more about it. http://bit.ly/bUAydR
Lipodystrophy, Localized: eMedicine Dermatology
emedicine.medscape.com — “Overview: Lipodystrophies are a heterogeneous group of diseases clinically characterized by a congenital or acquired loss of fat in circumscribed, partial, or diffuse areas of the body. As a rule, localized lipodystrophies are not associated with metabolic ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 19, 2010 at 6:45 pm By:
The gain or loss of fat in a particular area of the body is generally harmless, though perhaps unsightly. Learn causes. http://bit.ly/cwNzXU
Lipodystrophy, HIV: eMedicine Dermatology
emedicine.medscape.com — “Overview: HIV-associated lipodystrophy is a syndrome that occurs in individuals with HIV infection who are being treated with antiretroviral medications. Although the term HIV-associated lipodystrophy refers to abnormal central fat accumulation (lipohypertrophy) and localized loss of fat ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 19, 2010 at 6:18 pm By:
HIV patients may experience fat accumulation or fat loss from localized portions of the body. Learn why this happens. http://bit.ly/9EJaDJ
Egrifta Approved for HIV-Related Lipodystrophy
webmd.com — “The FDA has approved Egrifta, administered by daily injection, for the treatment of HIV lipodystrophy -- fat accumulation that is a side effect of AIDS drugs.” View full resource at webmd.com
Most Recently Shared on November 11, 2010 at 11:58 pm By:
Egrifta OK’d for Excess Fat Due to AIDS Drugs: The FDA has approved Egrifta, administered by daily injection, fo... http://bit.ly/dw8Z2L
Forum on Nutrition and Exercise: Lipodystrophy Without Meds
thebody.com — “Forum on Nutrition and Exercise: Lipodystrophy Without Meds” View full resource at thebody.com
Most Recently Shared on May 13, 2010 at 4:02 pm By:
Ask the HIV/AIDS Experts: "How Common Is Lipodystrophy in HIVers Not on Meds?" http://bit.ly/csno7O #hiv #aids #lipodystrophy
Forum on Nutrition and Exercise: Changing meds because of Lipodystrophy
thebody.com — “There is some evidence that switching from Norvir boosted protease inhibitors may, and I say MAY, decrease visceral fat in some patients that have metabolic issues. But in most patients, that is...” View full resource at thebody.com
Most Recently Shared on April 7, 2011 at 6:00 pm By:
Ask the HIV/AIDS Experts: "Am I Doing the Right Things to Reduce My Belly?" http://bit.ly/fPw48j #lipodystrophy #fat
Endocrinology News & Articles - MDLinx - Lipodystrophy on #MDlinx
mdlinx.com — “Endocrinology News & Articles - MDLinx - Lipodystrophy on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 28, 2010 at 8:45 am By:
Lipodystrophy: Metabolic insights from a rare disorder.: Journal of Endocrinology http://bit.ly/cL7nuR #endo
Metreleptin controlled diabetes, lipids in patients with lipodystrophy
endocrinetoday.com — “American Association of Clinical Endocrinologists 20th Annual Meeting SAN DIEGO --" Results from a new analysis of an ongoing, long-term resea” View full resource at endocrinetoday.com
Most Recently Shared on April 15, 2011 at 9:08 pm By:
Metreleptin controlled diabetes, lipids in patients with lipodystrophy (Endocrine Today): http://bit.ly/eiUxpG #AACE11
Lipodystrophy in HIV Disease | Consumer Health Video Library - Heath Video
healthvideo.com — “Lipodystrophy in HIV Disease” View full resource at healthvideo.com
Most Recently Shared on August 18, 2009 at 3:24 pm By:
Medicare Expands Coverage For Treating Facial Lipodystrophy Syndrome In People Living With HIV
medicalnewstoday.com — “The Centers for Medicare & Medicaid Services (CMS) announced its decision to cover facial injections for Medicare beneficiaries who experience symptoms of depression due to the stigmatizing appear” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2010 at 9:37 pm By:
Medicare Expands Coverage For Treating Facial Lipodystrophy Syndrome In People Living With HIV The Centers for Medica.. http://bit.ly/c8JaZV
FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV - The Body
thebody.com — “On November 10, 2010, the Food and Drug Administration approved Egrifta (tesamorelin) to treat HIV patients with lipodystrophy, a condition in which ...” View full resource at thebody.com
Most Recently Shared on November 11, 2010 at 1:01 pm By:
FDA Approves Egrifta for Treatment of Lipodystrophy in People With HIV http://www.thebody.com/content/art59376.html?tw #aids #fat #hump
Tesamorelin Approved to Treat Lipodystrophy in HIV Patients : Internal Medicine News
internalmedicinenews.com — “Tesamorelin Approved to Treat Lipodystrophy in HIV Patients : Internal Medicine News” View full resource at internalmedicinenews.com
Most Recently Shared on November 11, 2010 at 6:13 pm By:
FDA approves tesamorelin to treat lipodystrophy in HIV patients, @elizmech reports. http://bit.ly/dxPVix
Egrifta approved for HIV-associated abdominal lipodystrophy - ONA
oncologynurseadvisor.com — “Merck and EMD Serono announced that the FDA has approved Egrifta (tesamorelin for injection), a growth hormone releasing factor (GRF) analog, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 11, 2010 at 4:18 pm By:
Egrifta approved for HIV-associated abdominal lipodystrophy http://goo.gl/fb/7J3d9
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
Advertisement

